FDA boosting minority communities during pandemic

April 4, 2022

According to a release by the Food and Drug Administration (FDA), April is National Minority Health Month, and the U.S. Department of Health and Human Services selected “Give Your Community a Boost” as this year’s theme.

Over the last two years, the U.S. Food and Drug Administration has worked with our U.S. government partners, medical product manufacturers, international partners, and additional stakeholders to meet the challenges of COVID-19.

 Although the pandemic continues, significant strides have been made in efforts to protect the health of Americans. The FDA authorized and approved vaccines, treatments, increased available testing options such as at-home tests, and provided educational resources in a variety of languages.

 During National Minority Health Month, ways are highlighted in which to work to improve minority health and health equity. One aspect of “Give Your Community a Boost” centers on the continuous fight against COVID-19 and increasing health promotion through combatting misinformation and building trust with diverse communities.

 Over the last year, the FDA’s Office of Minority Health and Health Equity (OMHHE) launched a national outreach initiative to provide health education related to COVID-19. The office developed videos to highlight the diverse researchers who worked on the COVID-19 vaccines, the process of bringing vaccines to market, and the importance of diverse communities getting vaccinated. The videos are available in nine languages including American Sign Language. The office also developed other multi-media outreach materials to address vaccine confidence and support FDA efforts to combat COVID-19, including supporting translation of COVID-19 Vaccine EUA information for recipients and caregivers into more than 20 languages. 

 Health disparities that existed long before COVID-19 became amplified during the pandemic especially for racial and ethnic minority and tribal populations. OMHHE has made significant investments with stakeholders to advance health equity COVID-19 research. As part of our continued commitment and efforts, OMHHE’s newest initiative, the Enhance Equity Initiative, focuses on supporting research projects and communication resources to advance:

·        EQUITY in clinical trials by supporting efforts to advance diversity in participants.

·         EQUITABLE data efforts by increasing data available on diverse groups including, but not limited to, ethnicity, race, age, disability, and geography.

·         EQUITY of voices by amplifying the FDA’s communication with diverse groups to ensure stakeholders, including consumers, are informed about the FDA’s efforts, and to understand diverse patient perspectives, preferences, and unmet needs.

 Under this initiative, OMHHE also announced a COVID-19 and Health Equity Innovation Award, an award opportunity supported by funding from the American Rescue Plan Act of 2021 that will fund innovative projects to advance COVID-19 health equity research.

 FDA release